Hospitals of Cleveland. On entry to the study, height was measured on 239 probable or possible AD patients and 341 healthy controls living in northeast Ohio. Risk of AD was modeled as a function of quartile of height, APOE genotype, years of education and year of birth. Analyses were stratified by gender. For men, cases were more likely to be shorter when compared to controls (p = 0.001). There was only a small difference in mean height between AD cases and controls among women (p = 0.05). For men, height in the highest quartile [>179.7 cm (70.75 in)] had a 59% lower risk of developing AD that in the lowest quartile [<169.5 cm (66.75 in)], controlling for year of birth, and education (p = 0.03). For women without an APOE ε4 allele, increasing height was associated with lower risk for AD (OR = 0.88; p = 0.01) but no significant association was found for women with at least one ε4 allele (OR = 1.03; p = 0.56).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.